A case of Verruconis gallopava infection in a heart transplant recipient successfully treated with posaconazole.

Autor: Moran C; Department of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland., Delafield NL; Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona., Kenny G; Department of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland., Asbury KL; Division of Infectious Diseases, Mayo Clinic Hospital, Phoenix, Arizona., Larsen BT; Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona., Lambert KL; Department of Laboratory Medicine and Pathology, Mayo Clinic Hospital, Phoenix, Arizona., Patron RL; Division of Infectious Diseases, Mayo Clinic Hospital, Phoenix, Arizona.
Jazyk: angličtina
Zdroj: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2019 Apr; Vol. 21 (2), pp. e13044. Date of Electronic Publication: 2019 Jan 10.
DOI: 10.1111/tid.13044
Abstrakt: Verruconis gallopava is an environmental dematiaceous fungus that is recognized increasingly as a cause of human disease, especially for immunocompromised persons. Infection can range from superficial and localized lesions to pulmonary involvement and disseminated disease, including central nervous system abscesses. Optimal therapy is undefined. We report a patient post cardiac transplant who had pulmonary infection with V gallopava and was treated successfully with posaconazole.
(© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje